Skip to main content
FinSpry Logo
FinSpry
SRPT logo
SRPT
(NASDAQ)
Sarepta Therapeutics, Inc.
$22.02-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Sarepta Therapeutics, Inc. (SRPT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Sarepta Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 20 professional research analysts

Consensus Rating

Buy
Based on 20 unique analysts
(27 total ratings in last 90 days)
Very High Confidence2.0:1 Buy/Sell

Average Price Target

$23.09
↑ 4.86% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest SRPT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

fpak
StockTwits
BuyInitiates Coverage
-
Retter7
StockTwits
BuyInitiates Coverage
-
Richk515
StockTwits
BuyInitiates Coverage
-
Mitchell Kapoor
HC Wainwright
SellReiterates
$5.00
Biren Amin
Piper Sandler
HoldMaintains
$20.00
Yanan Zhu
Wells Fargo
BuyMaintains
$38.00
Gil Blum
Needham
SellReiterates
-
Michael Ulz
Morgan Stanley
HoldInitiates Coverage
$25.00
Kristen Kluska
Cantor Fitzgerald
HoldMaintains
$21.00
Brian Abrahams
RBC Capital
HoldMaintains
$19.00
epet3
StockTwits
SellInitiates Coverage
-
Yigal Nochomovitz
Citi
SellMaintains
$13.00
Yatish82
StockTwits
BuyInitiates Coverage
-
Prosper Junior Bakiny
The Motley Fool
SellInitiates Coverage
-
fpak
StockTwits
BuyInitiates Coverage
-
Uy Ear
Mizuho
BuyMaintains
$31.00
BioRich
StockTwits
BuyInitiates Coverage
-
Biren Amin
Piper Sandler
HoldReiterates
$20.00
Andy Chen
Wolfe Research
BuyUpgrades
$27.00
Brian Abrahams
RBC Capital
HoldMaintains
$19.00
Mitchell Kapoor
HC Wainwright
SellReiterates
$5.00
Michael Ulz
Morgan Stanley
HoldMaintains
$25.00
Yun Zhong
Wedbush
BuyMaintains
$35.00
Michael Ulz
Morgan Stanley
HoldMaintains
$25.00
Eliana Merle
Barclays
HoldMaintains
$20.00
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Brian Abrahams
RBC Capital
HoldMaintains
$19.00

Frequently Asked Questions

What is the analyst consensus rating for SRPT?

The analyst consensus rating for SRPT is "Buy" based on 20 analyst recommendations.

What is the average price target for SRPT?

The average 12-month price target for SRPT is $23.09, representing an upside of 4.9% from the current price of $22.02.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.